Douglas F S, O'Dair L C, Robinson M, Evans D G, Lynch S A
Department of Medical Genetics, St Mary's Hospital, Manchester, UK.
J Med Genet. 1999 Apr;36(4):309-12.
Assessment of risk of developing hereditary cancer and subsequent clinical surveillance is largely based on family history. It is considered standard practice to confirm as many diagnoses as possible in cancer families. Our aim was (1) to assess inaccuracies in reporting of cancers by families, (2) to assess the need for confirmation of diagnosis, and (3) to estimate how many families would have been entered unnecessarily or excluded from screening. A retrospective study of 595 case notes was performed in two centres. Methods of confirmation included information from the cancer registries, death certificates, hospital notes, and histopathological records. Accuracy varied by site of cancer and by the closeness of the relationship to the affected person. Reported abdominal malignancies were inaccurate in 20%, whereas 5% of reported breast cancers were inaccurate. In two families the family history of cancer proved fictitious. Management was altered in 231213 (11%) families following cancer confirmation. The results of the study favour verification of cancer diagnoses particularly if decisions regarding surveillance or prophylactic surgery are based on the family history.
遗传性癌症发生风险的评估及后续临床监测很大程度上基于家族病史。在癌症家族中尽可能多地确认诊断被视为标准做法。我们的目的是:(1)评估家族报告癌症时的不准确情况;(2)评估确诊的必要性;(3)估计有多少家族会被不必要地纳入筛查或被排除在筛查之外。在两个中心对595份病例记录进行了回顾性研究。确诊方法包括来自癌症登记处、死亡证明、医院病历和组织病理学记录的信息。准确性因癌症部位以及与患者关系的亲疏程度而异。报告的腹部恶性肿瘤有20%不准确,而报告的乳腺癌有5%不准确。在两个家族中,癌症家族史被证明是虚构的。确诊后,231213(11%)个家族的管理方式发生了改变。该研究结果支持对癌症诊断进行核实,尤其是在基于家族病史做出监测或预防性手术决策时。